In vivo bromodeoxyuridine (BrdUrd) labelling of the human large bowel was performed and a detailed histochemical localisation of label in' sections of crypts was undertaken using a monoclonal antibody to BrdUrd containing DNA. Flow cytometric studies on extracted nuclei were also performed (data presented elsewhere). The average crypt in the human large bowel (excluding the rectum) was 82 cells in height and 41 cells in circumference, with a total of about 2000 cells (assuming a topographical correction factor of 0.6). Ten per cent ofthe cells were replicating their DNA -that is, were in the S phase of the cell cycleand 0-4% were in mitosis. The median position for the labelling index versus cell position frequency plot is at the 20th cell position -at a quarter of the crypt height. The lower and upper limits of the cell proliferation are given by the 5th and 95th percentiles at cell positions 4 and 43 respectively. The peak labelling index is about 30% and it occurs at cell position 15. The labelling index at the crypt base, the probable stem cell zone, is about 14%, suggesting that these cells have a longer cell cycle.
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Taking a value of 8*6 hours for the duration of the S phase (deduced from the flow cytometric data) and assuming a growth fraction of 1 0 for the mid-crypt, these data provide an estimate of about 30 hours for the cell cycle time. The rectal crypts are about the same size but contain about 30% fewer S phase cells. The data also yielded a per cent BrdUrd labelled mitosis curve.
The study of the proliferation of gastrointestinal mucosa may provide clues to the development of disease states such as invasive adenocarcinoma. In the past cell kinetic data for human colorectal mucosa have been obtained mainly from in vitro radioisotope studies using tritiated thymidine, and vincristine induced metaphase arrest. In vivo studies have been severely limited by ethical and technical constraints. However, the principles of mucosal proliferation have been well characterised in animal studies, particularly of the mouse and rat colon.' 3 Parameters which have been studied include the distribution of S phase (proliferating) cells within crypts, mitotic indices, and crypt dimensions. The sequence of migration and differentiation of cells from the bottom of the crypts to the tip of the villus has also been studied.
Human mucosal proliferation may be modified in benign and malignant states -for example, in the mucosa of patients with ulcerative colitis, familial polyposis coli, and villous adenomas.1' Mucosal cell kinetics may also be modified by radiotherapy and endocrine, metabolic, or dietary changes.9 '0 The kinetics of normal mucosa may change with the presence and proximity of a tumour."I`I There may also be a change in proliferation with anatomical site along the colon.' 314 The labelling index of human colorectal mucosa has been measured using both in vitro and in vivo techniques, but these studies frequently involve only a few patients and rarely provide data on anatomical, or microscopical, topographical changes. In some studies dynamic data have been calculated (Table I) Figure 2 .
As well as producing histograms, the program was used to compute for each sample the overall mean labelling index, the mean labelling index for the first five positions, the 5th and 95th percentiles of the labelling index distribution, the median crypt length, the mitotic index, and measures of the peak of the labelling index distribution and runs of labelled cells. The distribution peak height and position were determined from the maximum of the 5- Because the flow cytometer does not distinguish between crypt and stromal cells, the machine cannot be used to measure the crypt labelling index unless a correction is made for the standard proportions of the cells based on manual counting of tissue sections. However, S phase calculations based on the relative movement (mean DNA content) oflabelled cells from S into G2 are applicable, because the large majority of S phase cells are cryptal rather than stromal.
STATISTICAL METHODS
Comparisons between the various subgroups (area, age, and sex) were performed using the non-parametric Mann-Whitney U test and Kruskal-Wallis one way analysis of variance. As there were significant differences between the Table II for details). The standard error limits are shown by the upper and lower thin lines. The effects of time were analysed using (i) Kruskal-Wallis tests on the data grouped into time bands; (ii) two way analysis of variance by area and time band; and (iii) linear regression against time with a term included to differentiate the rectal samples. An interaction term was considered but never reached significance. As the main effects of time would be expected during the earlier times, the regression was performed on all times <7 hours and repeated for times < 10 hours. As there were no significant effects of time (other than on per cent labelled BrdUrd labelled mitosis curve) all time points were combined in the other analysis.
Heterogeneity was assessed using two way analysis of variance with area and patient, taking advantage of the fact that there were multiple samples from some patients. There were insufficient samples to allow the inclusion of a time factor in this analysis. A significance level of 005 was used throughout.
PER CENT LABELLED BrdUrd MITOSIS ANALYSIS
A two way analysis of variance by time and area shows no significant difference in per cent labelled (BrdUrd) mitoses between the areas; therefore all areas were pooled. The curve was produced by pooling all the mitoses for all the patients sampled within successive one hour time bands. At later times larger time bands were used to increase the total number of mitoses assessed. A smooth curve drawn through the data was used as input to a modified version of the Gilbert25 program (SA Roberts, unpublished) and cell cycle parameters estimates obtained.
Results

SPECIMENS STUDIED
A total of 107 separate specimens of colorectal mucosa from 66 patients with adenocarcinomas were amenable to analysis. All were entirely normal by conventional histology. The samples were separated into seven different groups according to site. Since no significant differences were detected between the caecum and the right colon and since the distinction between these two areas is somewhat arbitrary, they were pooled. Similar reasoning led to us pool the data for the sigmoid and rectosigmoid junctional regions. This left us with five sites for comparison.
PROLIFERATIVE PARAMETERS
There were no significant differences by any criterion measured in any site in the colon (see Fig 3,  Cell position Figure 4 : A comparison ofthe labelling index frequency plots for the colon (77 samples pooled) and the rectum (30 samples) (see Table IIfor Since there was no significant difference between any of the colonic sites they were pooled for comparison with the rectum which showed a significant difference in many of the parameters (see Fig 4, labelling index or the clustering of labelle with time after injection although both la index and the frequency of labelled increased with time. However, the data; inronsistent with an increase in labelling with time of a magnitude expected based kinetics of the system. The per cent E labelled mitosis curve did show a sigr change with time (Fig 5) . Analysis of this dampened curve using the Gilbert fittin gramme25 provided an estimate for T, hours (coefficient of variation of Ts+G2= highly There is significant inter-and intrapatient variig pro-ability. The mean labelling index shows a 50% of 4-9 coefficient of variation between patients after =67%), accounting for the differences in gut area whichfor G2, is significantly greater than the 26% coefficient of 7%) for variation within patients. The variation between samples from the same patient (26% coefficient of variation) is significantly greater than the 5% expected simply from Poisson counting errors. This intrapatient heterogeneity can be brought 5 phase about by either variability in the sample preparaby the tions and analysis, or real variability from site to site within the same region of the colon. The presence of the BrdUrd S phase label within tissues also provides a marker with which other proliferation associated antigens and cell proteins can be compared, and the relation of p62cmyc protein synthesis to BrdUrd labelling in this material is being undertaken.
RESULTS
Past studies of human mucosal kinetics have tended to report on a small series of patients using in vitro labelling and often unspecified sites (Table I) . Published labelling index and T.
values range widely, but our own extensive in vivo data lay at the median for both indices. This series is the largest yet reported of the proliferation characteristics of normal human colorectal mucosa. We acknowledge the possible criticism that all material was derived from patients with colorectal cancer and that in some way this tissue may differ from the normal human colon. However, detailed histological assessment has not shown any unusual features of this material, and all specimens were removed at least 5 0 cm from the primary carcinoma. We are currently studying the relation between mucosal proliferation and distance from the carcinoma and will report this in due course.
Our measurement of crypt length is somewhat greater than that in some published series.'23' This may be due to differences in defining the top of the crypt. We have standardised our crypt counting to a point beyond the inflexure of the crypt orifice as described. Differences may also have arisen in the selection criteria for counting crypts, and we emphasise the value of selecting good longitudinal crypts. A further source of variation lies in the method of handling overlapping nuclei. Our data are, however, consistent with absolute measurements of cells per crypt. 27 The partial per cent BrdUrd labelled mitosis curve obtained is highly damped, with large coefficient of variations for all the parameters. In this situation particularly the curve does not extend much beyond the first peak, and one cannot expect very reliable estimates of cell cycle parameters. The large heterogeneity in kinetic parameters, while biologically realistic,-makes the estimates of the kinetic parameters sensitive to the exact functional form assumed for the distributions of the cell cycle parameters. We estimate that the parameters given are correct to within a factor of two, but would be reluctant to claim greater precision.
The systematic and standardised method of analysis of mucosal proliferation in vivo is a valuable tool for clinical studies of gastrointestinal diseases which are believed to be associated with altered proliferation -for example, familial polyposis coli, ulcerative colitis, and the putative mucosa-polyp-tumour proliferation sequence.
We have not so far identified any features of mucosal proliferation which may correlate with the development of a tumour. The colorectum is heterogeneous with regard to the risk of developing malignancy. For example, although 50% of all large bowel carcinomas develop at or below the rectosigmoid junction,32 virtually none arise in the more rapidly proliferating ileum. It is thus of interest that the proliferation characteristics of the colon are remarkably homogeneous along most of its length, and that the rectum seems to have a lower rate of proliferation than the colon but a higher cancer incidence.
We conclude that the combination ofquantitative techniques that we have described offers substantial advantages for the study of colorectal mucosal proliferation, both in animal models and in human diseases where the clinical circumstances are appropriate. Our data will form the basis for further investigations into the relation between crypt cell turnover and colorectal proliferative diseases.
